IL-8 is a potent neutrophil chemoattractant, and we reasoned that the interplay between prostate cancer cells and bone marrow MSCs could result in the recruitment of neutrophils within the bone-PCa microenvironment. Here, CXCL8 is linked to prostate carcinoma.